Literature DB >> 18179643

Simple genotyping of functional polymorphisms of the human immunoglobulin G receptors CD16A and CD32A: a reference cell panel.

C Vilches1, J Castaño, P Muñoz, J Peñalver.   

Abstract

The Fcgamma receptors CD16A and CD32A connect the innate and the adaptive immune responses by transmitting activating signals to natural killer lymphocytes and myeloid cells upon recognition of antigen-immunoglobulin G (IgG) complexes. Two allelic dimorphisms of these receptors, valine/phenylalanine-158 of CD16A and histidine/arginine-131 of CD32A, modulate their affinity for certain human IgG subclasses. Furthermore, these polymorphisms are clinically relevant because they modify the susceptibility, the clinical course and the response to therapy of several human diseases. Genotyping of CD16A and CD32A alleles, encoded by FCGR3A and FCGR2A, respectively, is complicated by the fact that they both belong to families of highly homologous genes. In this study, we present an original method for genotyping the FCGR3A and FCGR2A dimorphisms based on the technique of polymerase chain reaction with confronting two-pair primers. The new method simplifies the analysis of FCGR3A and FCGR2A because the two alleles of each gene are detected simultaneously in a single reaction and separated, with no further manipulations, by their different electrophoretic mobilities in regular agarose gels. We also present the CD16A and CD32A genotypes of cells from the Tenth International Histocompatibility Workshop, which can serve as a reference cell panel for investigating the influence of CD16A and CD32A polymorphisms on human health.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18179643     DOI: 10.1111/j.1399-0039.2007.00998.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  3 in total

1.  Case Report: High Doses of Intravenous Immunoglobulins as a Successful Treatment for Late Onset Immune Agranulocytosis After Rituximab Plus Bendamustine.

Authors:  Ramon Diez-Feijóo; Juan Jose Rodríguez-Sevilla; Concepcion Fernández-Rodríguez; Solange Flores; Carmen Raya; Ana Ferrer; Luis Colomo; Antonio Salar
Journal:  Front Immunol       Date:  2022-01-10       Impact factor: 7.561

2.  Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines.

Authors:  Silvia Boero; Anna Morabito; Barbara Banelli; Barbara Cardinali; Beatrice Dozin; Gianluigi Lunardi; Patrizia Piccioli; Sonia Lastraioli; Roberta Carosio; Sandra Salvi; Alessia Levaggi; Francesca Poggio; Alessia D'Alonzo; Massimo Romani; Lucia Del Mastro; Alessandro Poggi; Maria Pia Pistillo
Journal:  J Transl Med       Date:  2015-10-08       Impact factor: 5.531

3.  A simple genotyping method for CD247 3'-untranslated region polymorphism rs1052231 and characterization of a reference cell panel.

Authors:  Karima Al-Akioui-Sanz; Manuela Moraru; Carlos Vilches
Journal:  HLA       Date:  2021-07-16       Impact factor: 8.762

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.